Barclay, Nicola L.Burn, EdwardDelmestri, AntonellaDuarte-Salles, TalitaGolozar, AsiehMan, Wai YiTan, Eng HooiTietzova, IlonaOPTIMA ConsortiumPrieto-Alhambra, DanielNewby, Danielle2024-09-252024-09-252024-08-17Barclay, N L, Burn, E, Delmestri, A, Duarte-Salles, T, Golozar, A, Man, W Y, Tan, E H, Tietzova, I, OPTIMA Consortium, Prieto-Alhambra, D & Newby, D 2024, 'Trends in incidence, prevalence, and survival of breast cancer in the United Kingdom from 2000 to 2021', Scientific Reports, vol. 14, 19069. https://doi.org/10.1038/s41598-024-69006-12045-2322ORCID: /0000-0002-1000-3649/work/167615782ORCID: /0000-0002-0602-4666/work/167615786ORCID: /0000-0003-1405-6964/work/167615824ORCID: /0000-0002-2691-8421/work/167616271https://hdl.handle.net/2164/24293Professor Daniel Prieto-Alhambra\u2019s research group has received research grants from the European Medicines Agency from the Innovative Medicines Initiative from Amgen Chiesi and from UCB Biopharma; and consultancy or speaker fees (paid to his department) from Astellas Amgen Astra Zeneca and UCB Biopharma. NLB is Director of Sleep Universal Limited (though this work is in no way connected to the present manuscript). All other authors declare no conflicts of interest.165470403engSDG 3 - Good Health and Well-beingHumansUnited Kingdom/epidemiologyFemaleMiddle AgedAgedMaleIncidenceAdultBreast Neoplasms/epidemiologyPrevalenceAged, 80 and overAdolescentYoung AdultBreast Neoplasms, Male/epidemiologySurvival RateR Medicine (General)GeneralR1Journal article10.1038/s41598-024-69006-1http://www.scopus.com/inward/record.url?scp=85201543350&partnerID=8YFLogxK14